Eur Respir J 1996; 9: 560-564
Copyright © ERS Journals Ltd 1996
Role of NO in the pulmonary artery hyporeactivity to phenylephrine in experimental biliary cirrhosis
F Chabot,
H Mestiri,
S Sabry,
J Dall'Ava-Santucci,
A Lockhart,
and
AT Dinh-Xuan
The aim of this study was to see whether increased activity of nitric oxide (NO) might account for decreased pulmonary vascular tone seen in the hyperdynamic circulation of cirrhosis. We compared the pulmonary vascular reactivity of isolated pulmonary arteries (PA) from control rats (n = 10), and rats with biliary cirrhosis (n = 10) induced by chronic bile duct ligation (4 weeks). The responses of PA rings to cumulative concentrations of phenylephrine, acetylcholine, and sodium nitroprusside were studied, and also the effects of inhibition of synthesis of NO by the L-arginine analogue, N omega-nitro-L-arginine (L-NOARG) in PA rings challenged with cumulative concentrations of phenylephrine and acetylcholine. The contractile response to phenylephrine was significantly reduced in cirrhotic PA rings as compared with controls. Pretreatment with L-NOARG (10(-4) M) significantly increased the contractile response to phenylephrine in PA rings from cirrhotic rats but not in control PA rings. Furthermore, L-NOARG restored the response to phenylephrine in cirrhotic PA rings back to normal. There was no difference in the relaxation of PA rings from both groups in response to acetylcholine and sodium nitroprusside. We conclude that in vitro pulmonary artery ring hyporeactivity to phenylephrine results from increased nitric oxide production in the pulmonary circulation of cirrhotic rats and might account for the hepatopulmonary syndrome.
This article has been cited by other articles:

|
 |

|
 |
 
J. Tieppo, M. J. Cuevas, R. Vercelino, M. J. Tunon, N. P. Marroni, and J. Gonzalez-Gallego
Quercetin Administration Ameliorates Pulmonary Complications of Cirrhosis in Rats
J. Nutr.,
July 1, 2009;
139(7):
1339 - 1346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.T. Dinh-Xuan and R. Naeije
The hepatopulmonary syndrome: NO way out?
Eur. Respir. J.,
May 1, 2004;
23(5):
661 - 662.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. NUNES, D. LEBREC, M. MAZMANIAN, F. CAPRON, J. HELLER, K. A. TAZI, E. ZERBIB, E. DULMET, R. MOREAU, A. T. DINH-XUAN, et al.
Role of Nitric Oxide in Hepatopulmonary Syndrome in Cirrhotic Rats
Am. J. Respir. Crit. Care Med.,
September 1, 2001;
164(5):
879 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-N. Lee, H.-J. Lee, W. W. Shin, and W. R. Webb
Hypoxemia and Liver Cirrhosis (Hepatopulmonary Syndrome) in Eight Patients: Comparison of the Central and Peripheral Pulmonary Vasculature
Radiology,
May 1, 1999;
211(2):
549 - 553.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1996 by the European Respiratory Society.
|